Respiratory Syncytial Virus Infection: Treatments and Clinical Management
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Respiratory Syncytial Virus Infection: Treatments and Clinical Management
Authors
Keywords
-
Journal
Vaccines
Volume 11, Issue 2, Pages 491
Publisher
MDPI AG
Online
2023-02-21
DOI
10.3390/vaccines11020491
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)
- (2023) Dvir Gatt et al. Pathogens
- Structure-Based Design and Antigenic Validation of Respiratory Syncytial Virus G Immunogens
- (2022) Ana M. Nuñez Castrejon et al. JOURNAL OF VIROLOGY
- Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis
- (2022) You Li et al. LANCET
- Prefusion F Protein–Based Respiratory Syncytial Virus Immunization in Pregnancy
- (2022) Eric A.F. Simões et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predicting prolonged length of stay in hospitalized children with respiratory syncytial virus
- (2022) Krista Wollny et al. PEDIATRIC RESEARCH
- Mucosal Immune Responses to Respiratory Syncytial Virus
- (2022) Megan V. C. Barnes et al. Cells
- Respiratory Syncytial Virus Disease in Young Children and Older Adults in Europe: A Burden and Economic Perspective
- (2022) Eric A F Simões JOURNAL OF INFECTIOUS DISEASES
- Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study
- (2022) Beate Schmoele-Thoma et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Infection and Pathogenesis in a Novel Mouse Model of Human Respiratory Syncytial Virus
- (2022) Rui Xiong et al. Viruses-Basel
- RSV disease in infants and young children: Can we see a brighter future?
- (2022) Eugenio Baraldi et al. Human Vaccines & Immunotherapeutics
- Self-Amplifying RNA Approach for Protein Replacement Therapy
- (2022) Dimitri Papukashvili et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Respiratory syncytial virus, recurrent wheeze and asthma: A narrative review of pathophysiology, prevention and future directions
- (2022) Elly Binns et al. JOURNAL OF PAEDIATRICS AND CHILD HEALTH
- Vaccines against Emerging and Neglected Infectious Diseases: An Overview
- (2022) Larissa Vuitika et al. Vaccines
- Respiratory Syncytial Virus Two-Step Infection Screen Reveals Inhibitors of Early and Late Life Cycle Stages
- (2022) Svenja M. Sake et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nucleoside analogs for management of respiratory virus infections: mechanism of action and clinical efficacy
- (2022) Annelies Stevaert et al. Current Opinion in Virology
- Development of mRNA Vaccines: Scientific and Regulatory Issues
- (2021) Ivana Knezevic et al. Vaccines
- Adjuvant Selection for Influenza and RSV Prefusion Subunit Vaccines
- (2021) Ariel Isaacs et al. Vaccines
- The Versatile Manipulations of Self-Assembled Proteins in Vaccine Design
- (2021) Que Dan Nguyen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Future of Respiratory Syncytial Virus Disease Prevention and Treatment
- (2021) Joseph B. Domachowske et al. Infectious Diseases and Therapy
- Upper and lower respiratory tract correlates of protection against respiratory syncytial virus following vaccination of nonhuman primates
- (2021) Tomer Zohar et al. Cell Host & Microbe
- Breakthrough therapy designation of nirsevimab for the prevention of lower respiratory tract illness caused by respiratory syncytial virus infections (RSV)
- (2021) Harrison C. Bergeron et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Are We Ready for Maternal Respiratory Syncytial Virus Vaccination?
- (2021) Emily W E M Phijffer et al. JOURNAL OF INFECTIOUS DISEASES
- Respiratory Syncytial Virus Resurgence in Italy: The Need to Protect All Neonates and Young Infants
- (2021) Elena Bozzola International Journal of Environmental Research and Public Health
- The Development of mRNA Vaccines for Infectious Diseases: Recent Updates
- (2021) Nitika et al. Infection and Drug Resistance
- A codon-pair deoptimized live-attenuated vaccine against respiratory syncytial virus is immunogenic and efficacious in non-human primates
- (2020) Steffen Mueller et al. VACCINE
- RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs
- (2020) Sarah Bajan et al. Cells
- Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection
- (2020) Amy S. Espeseth et al. npj Vaccines
- Infection prophylaxis and management of viral infection
- (2020) Emily S. Clausen et al. Annals of Translational Medicine
- Multiepitope-Based Subunit Vaccine Design and Evaluation against Respiratory Syncytial Virus Using Reverse Vaccinology Approach
- (2020) Muhammad Tahir ul Qamar et al. Vaccines
- Live-attenuated Vaccines Prevent Respiratory Syncytial Virus-associated Illness in Young Children
- (2020) Ruth A Karron et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pharmacological management of human respiratory syncytial virus infection
- (2020) Alexis M. Kalergis et al. EXPERT OPINION ON PHARMACOTHERAPY
- Role of Respiratory Syncytial Virus in Pediatric Pneumonia
- (2020) Sonia Bianchini et al. Microorganisms
- New therapies for acute RSV infections: where are we?
- (2019) Ying Xing et al. EUROPEAN JOURNAL OF PEDIATRICS
- Nucleoside analogues for the treatment of coronavirus infections
- (2019) Andrea J Pruijssers et al. Current Opinion in Virology
- Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine Development
- (2019) Seyhan Boyoglu-Barnum et al. Frontiers in Immunology
- A Contemporary View of Respiratory Syncytial Virus (RSV) Biology and Strain-Specific Differences
- (2019) Mansi C. Pandya et al. Pathogens
- Immunological goals for respiratory syncytial virus vaccine development
- (2019) Barney S Graham CURRENT OPINION IN IMMUNOLOGY
- Immunological Lessons from Respiratory Syncytial Virus Vaccine Development
- (2019) Tracy J. Ruckwardt et al. IMMUNITY
- Respiratory syncytial virus (RSV): a scourge from infancy to old age
- (2019) James Andrew Coultas et al. THORAX
- Antiviral and Immunomodulatory Activity of Silver Nanoparticles in Experimental RSV Infection
- (2019) Dorothea Morris et al. Viruses-Basel
- Human Antiviral Efficacy, Safety and Pharmacokinetics of RV521, an Inhibitor of the RSV-F Protein: A Randomized, Placebo-Controlled, Respiratory Syncytial Virus Challenge Study
- (2019) John DeVincenzo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Summary of the Vaccines and Related Biological Products Advisory Committee meeting held to consider evaluation of vaccine candidates for the prevention of respiratory syncytial virus disease in RSV-naïve infants
- (2019) Sarah K. Browne et al. VACCINE
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Genetic variations in the fusion protein of respiratory syncytial virus isolated from children hospitalized with community-acquired pneumonia in China
- (2018) Xiangpeng Chen et al. Scientific Reports
- A Review of Therapeutics in Clinical Development for Respiratory Syncytial Virus and Influenza in Children
- (2018) Erin G. Nicholson et al. CLINICAL THERAPEUTICS
- The antiviral effects of RSV fusion inhibitor, MDT-637, on clinical isolates, vs its achievable concentrations in the human respiratory tract and comparison to ribavirin
- (2017) Young-In Kim et al. Influenza and Other Respiratory Viruses
- Estimating the burden of respiratory syncytial virus (RSV) on respiratory hospital admissions in children less than five years of age in England, 2007-2012
- (2017) Rachel Melanie Reeves et al. Influenza and Other Respiratory Viruses
- Inhibitors of Influenza Virus Polymerase Acidic (PA) Endonuclease: Contemporary Developments and Perspectives
- (2017) Han Ju et al. JOURNAL OF MEDICINAL CHEMISTRY
- Respiratory Syncytial Virus: Targeting the G Protein Provides a New Approach for an Old Problem
- (2017) Ralph A. Tripp et al. JOURNAL OF VIROLOGY
- Enhancing the Thermostability and Immunogenicity of a Respiratory Syncytial Virus (RSV) Live-Attenuated Vaccine by Incorporating Unique RSV Line19F Protein Residues
- (2017) Christina A. Rostad et al. JOURNAL OF VIROLOGY
- Correction: Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B
- (2017) Anne M. Hause et al. PLoS One
- Development and clinical applications of novel antibodies for prevention and treatment of respiratory syncytial virus infection
- (2017) Asuncion Mejias et al. VACCINE
- Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor
- (2017) Dirk Roymans et al. Nature Communications
- Vaccine development for respiratory syncytial virus
- (2017) Barney S Graham Current Opinion in Virology
- Respiratory syncytial virus: prospects for new and emerging therapeutics
- (2017) Patricia A. Jorquera et al. Expert Review of Respiratory Medicine
- Activation Pathway of a Nucleoside Analog Inhibiting Respiratory Syncytial Virus Polymerase
- (2016) Paul C. Jordan et al. ACS Chemical Biology
- New antiviral approaches for respiratory syncytial virus and other mononegaviruses: Inhibiting the RNA polymerase
- (2016) Rachel Fearns et al. ANTIVIRAL RESEARCH
- Long-acting Neuraminidase Inhibitor Laninamivir Octanoate as Post-exposure Prophylaxis for Influenza
- (2016) Seizaburo Kashiwagi et al. CLINICAL INFECTIOUS DISEASES
- Structure-guided design of small-molecule therapeutics against RSV disease
- (2016) Robert Cox et al. Expert Opinion on Drug Discovery
- Vesicles and micelles: Two versatile vectors for the delivery of natural products
- (2016) Anna Rita Bilia et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Nanostructured glycan architecture is important in the inhibition of influenza A virus infection
- (2016) Seok-Joon Kwon et al. Nature Nanotechnology
- Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative
- (2016) O.E. Beaird et al. Transplant Infectious Disease
- Challenges and opportunities in RSV vaccine development: Meeting report from FDA/NIH workshop
- (2016) Jeffrey N. Roberts et al. VACCINE
- Discovery of Piperazinylquinoline Derivatives as Novel Respiratory Syncytial Virus Fusion Inhibitors
- (2016) Xiufang Zheng et al. ACS Medicinal Chemistry Letters
- A Decade of Respiratory Syncytial Virus Epidemiology and Prophylaxis: Translating Evidence into Everyday Clinical Practice
- (2016) Bosco A Paes et al. Canadian Respiratory Journal
- Antiviral Efficacy of a Respiratory Syncytial Virus (RSV) Fusion Inhibitor in a Bovine Model of RSV Infection
- (2015) Robert Jordan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Different applications of virus-like particles in biology and medicine: Vaccination and delivery systems
- (2015) Zeinab Shirbaghaee et al. BIOPOLYMERS
- Novel antigens for RSV vaccines
- (2015) Barney S Graham et al. CURRENT OPINION IN IMMUNOLOGY
- Recent advances in the development of subunit-based RSV vaccines
- (2015) Noushin Jaberolansar et al. Expert Review of Vaccines
- New options in the treatment of respiratory syncytial virus disease
- (2015) Asuncion Mejias et al. JOURNAL OF INFECTION
- Discovery of 4′-Chloromethyl-2′-deoxy-3′,5′-di-O-isobutyryl-2′-fluorocytidine (ALS-8176), A First-in-Class RSV Polymerase Inhibitor for Treatment of Human Respiratory Syncytial Virus Infection
- (2015) Guangyi Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Molecular mechanism of respiratory syncytial virus fusion inhibitors
- (2015) Michael B Battles et al. Nature Chemical Biology
- Enhanced immunogenicity of a respiratory syncytial virus (RSV) F subunit vaccine formulated with the adjuvant GLA-SE in cynomolgus macaques
- (2015) Kathryn Patton et al. VACCINE
- A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism
- (2015) Anders Krarup et al. Nature Communications
- Cross-protection against influenza virus infection by intranasal administration of nucleoprotein-based vaccine with compound 48/80 adjuvant
- (2015) Mei Zheng et al. Human Vaccines & Immunotherapeutics
- siRNA Versus miRNA as Therapeutics for Gene Silencing
- (2015) Jenny K W Lam et al. Molecular Therapy-Nucleic Acids
- Influence of age, severity of infection, and co-infection on the duration of respiratory syncytial virus (RSV) shedding
- (2014) P. K. MUNYWOKI et al. EPIDEMIOLOGY AND INFECTION
- Current concepts and progress in RSV vaccine development
- (2014) Aleks K Guvenel et al. Expert Review of Vaccines
- Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis
- (2014) Raymond J Pickles et al. JOURNAL OF PATHOLOGY
- Epidemiological Changes of Respiratory Syncytial Virus (RSV) Infections in Israel
- (2014) Shira Hirsh et al. PLoS One
- Comparing influenza and RSV viral and disease dynamics in experimentally infected adults predicts clinical effectiveness of RSV antivirals
- (2013) Bindiya Bagga et al. ANTIVIRAL THERAPY
- Respiratory Syncytial Virus—A Comprehensive Review
- (2013) Andrea T. Borchers et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Induction of mucosal immunity and protection by intranasal immunization with a respiratory syncytial virus subunit vaccine formulation
- (2013) R. Garg et al. JOURNAL OF GENERAL VIROLOGY
- Reversion of Somatic Mutations of the Respiratory Syncytial Virus-Specific Human Monoclonal Antibody Fab19 Reveal a Direct Relationship between Association Rate and Neutralizing Potency
- (2013) J. T. Bates et al. JOURNAL OF IMMUNOLOGY
- Respiratory syncytial virus: How, why and what to do
- (2013) Rosa Rodriguez et al. JOURNAL OF INFECTION
- Progress and Challenges in RSV Prophylaxis and Vaccine Development
- (2013) L. M. Haynes JOURNAL OF INFECTIOUS DISEASES
- A Novel Influenza Virus Hemagglutinin-Respiratory Syncytial Virus (RSV) Fusion Protein Subunit Vaccine against Influenza and RSV
- (2013) T. M. Turner et al. JOURNAL OF VIROLOGY
- Motavizumab Treatment of Infants Hospitalized With Respiratory Syncytial Virus Infection Does Not Decrease Viral Load or Severity of Illness
- (2013) Octavio Ramilo et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Latitudinal Variations in Seasonal Activity of Influenza and Respiratory Syncytial Virus (RSV): A Global Comparative Review
- (2013) Kimberly Bloom-Feshbach et al. PLoS One
- Strategic priorities for respiratory syncytial virus (RSV) vaccine development
- (2013) L.J. Anderson et al. VACCINE
- Prophylaxis and Treatment of Respiratory Syncytial Virus in Adult Immunocompromised Patients
- (2012) Lauren M Hynicka et al. ANNALS OF PHARMACOTHERAPY
- Prophylactic, therapeutic and neutralizing effects of zinc oxide tetrapod structures against herpes simplex virus type-2 infection
- (2012) Thessicar E. Antoine et al. ANTIVIRAL RESEARCH
- Inflammatory Responses to Respiratory Syncytial Virus (RSV) Infection and the Development of Immunomodulatory Pharmacotherapeutics
- (2012) H. F. Rosenberg et al. CURRENT MEDICINAL CHEMISTRY
- Respiratory Syncytial Virus Modified by Deletions of the NS2 Gene and Amino Acid S1313 of the L Polymerase Protein Is a Temperature-Sensitive, Live-Attenuated Vaccine Candidate That Is Phenotypically Stable at Physiological Temperature
- (2012) C. Luongo et al. JOURNAL OF VIROLOGY
- Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles
- (2012) S. Garlapati et al. VACCINE
- Perinatal Lamb Model of Respiratory Syncytial Virus (RSV) Infection
- (2012) Rachel J. Derscheid et al. Viruses-Basel
- Natural Polymorphisms and Resistance-Associated Mutations in the Fusion Protein of Respiratory Syncytial Virus (RSV): Effects on RSV Susceptibility to Palivizumab
- (2011) Qing Zhu et al. JOURNAL OF INFECTIOUS DISEASES
- Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV)
- (2011) A. Bonavia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-inflammatory effect of MUC1 during respiratory syncytial virus infection of lung epithelial cells in vitro
- (2010) Yusheng Li et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Pharmacologic Advances in the Treatment and Prevention of Respiratory Syncytial Virus
- (2010) Kerry M. Empey et al. CLINICAL INFECTIOUS DISEASES
- Pharmacotherapy of respiratory syncytial virus infection
- (2010) Robert C Welliver CURRENT OPINION IN PHARMACOLOGY
- Respiratory syncytial virus disease: update on treatment and prevention
- (2010) Leonard R Krilov Expert Review of Anti-Infective Therapy
- Biological challenges and technological opportunities for respiratory syncytial virus vaccine development
- (2010) Barney S. Graham IMMUNOLOGICAL REVIEWS
- Anti-inflammatory effect of resveratrol on adipokine expression and secretion in human adipose tissue explants
- (2010) J Ølholm et al. INTERNATIONAL JOURNAL OF OBESITY
- Emerging Influenza Antiviral Resistance Threats
- (2010) F. G. Hayden et al. JOURNAL OF INFECTIOUS DISEASES
- Prophylactic Treatment with a G Glycoprotein Monoclonal Antibody Reduces Pulmonary Inflammation in Respiratory Syncytial Virus (RSV)-Challenged Naive and Formalin-Inactivated RSV-Immunized BALB/c Mice
- (2010) G. U. Radu et al. JOURNAL OF VIROLOGY
- Respiratory syncytial virus market
- (2009) Shane Storey NATURE REVIEWS DRUG DISCOVERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now